Related Experiment Video
Updated: Aug 8, 2026
06:22
Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice
Published on: September 17, 2015
Influence of cardiac dysfunction on fast sodium current regulation by Forskolin
1Medizinische Universitätsklinik, Würzburg, Germany.
Pacing and Clinical Electrophysiology : PACE
|November 1, 1996
Summary
In heart failure, the fast cardiac sodium current (INa+) regulation is altered. Direct stimulation of adenylyl cyclase maintains INa+ function, suggesting beta-receptor desensitization in cardiac dysfunction.
Area of Science:
- Cardiology
- Molecular Cardiology
- Physiology
Background:
- Altered beta-adrenergic signaling is reported in heart failure.
- The fast cardiac sodium current (INa+) is regulated by beta-receptors.
- Cardiac dysfunction impacts beta-adrenergic pathways.
Purpose of the Study:
- To investigate the regulation of the fast cardiac sodium current (INa+) in a model of cardiac dysfunction.
- To determine if beta-receptor desensitization affects INa+ regulation in heart failure.
Main Methods:
- Myocardial infarction induced in Wistar rats via coronary artery ligation.
- Hemodynamic changes evaluated by left ventricular end-diastolic pressure (LVEDP).
- Fast cardiac sodium current (INa+) measured using loose patch clamp technique.
Main Results:
- Forskolin (adenylyl cyclase activator) increased INa+ in both minor and significant infarction groups.
- The increase in INa+ by forskolin was similar in healthy and infarcted animals.
- This suggests a preserved adenylyl cyclase function despite altered beta-receptor signaling.
Conclusions:
- The fast cardiac sodium current (INa+) regulation is maintained via direct adenylyl cyclase stimulation in heart failure.
- Findings support a hypothesis of beta-receptor down-regulation or desensitization in this cardiac dysfunction model.
- This implies specific molecular mechanisms underlying altered beta-adrenergic pathway function in heart failure.
Related Concept Videos
01:19Electrophysiology of Normal Cardiac Rhythm
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
01:29Pathophysiology of Cardiac Performance
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Cardiac Action Potential
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...